Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07791108 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Outcomes of Intra-articular Steroid Injection Via Ultrasound Guidance Versus Fluoroscopic Guidance in the Sacroiliac Joint in Patients With Sacroiliitis

StatusNot Yet Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 43 days later Oct 15, 2026 → Nov 27, 2026
See other at-risk trials from Allied Hospital Faisalabad

Record History

See every version on ClinicalTrials.gov ↗

  1. Notable Start date pushed from Aug 25, 2026 to Sep 27, 2026
    • Primary completion pushed from Oct 15, 2026 to Nov 27, 2026
    • Study completion pushed from Oct 25, 2026 to Nov 27, 2026
  2. Minor Eligibility criteria expanded, about 9 words
    • Secondary endpoints: details revised at 1 of 1 entry
  3. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Sacroiliitis is a common cause of low back and buttock pain. Intra-articular steroid injection of the sacroiliac joint can provide pain relief and functional improvement. This randomized controlled trial aims to compare the outcomes of ultrasound-guided versus fluoroscopic-guided sacroiliac joint steroid injections in patients with sacroiliitis. The study will evaluate procedural success, pain reduction, and functional improvement using the Visual Analogue Scale (VAS) and Oswestry Disability Index (ODI) at follow-up intervals.
Trial Details
NCT Number NCT07791108
Lead Sponsor Allied Hospital Faisalabad
Conditions
(from sponsor)
Sacroiliitis
Related terms Sacroiliitis
Enrollment 176 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov